Trial Profile
Phase II study of antineoplastons A10 and AS2-1 capsules with total androgen blockade in patients with stage III or IV adenocarcinoma of the prostate
Status:
Withdrawn prior to enrolment
Phase of Trial:
Phase II
Latest Information Update: 08 Jul 2013
Price :
$35
*
At a glance
- Drugs Antineoplaston-A10 (Primary) ; Antineoplaston-AS2-1 (Primary) ; Bicalutamide; Flutamide; Leuprorelin
- Indications Prostate cancer
- Focus Therapeutic Use
- 12 Dec 2006 Status change
- 09 Oct 2005 New trial record.